Home

Journal

Articles

Login
Sciences of Pharmacy
Creative Commons License
Open Access
DOAJ
EBSCO
Scilit
Garuda
Crossref
Harvard Library
Universiteit Leiden
Google Scholar
Index Copernicus
DRJI
WorldCat
BASE
ROAD
OAISter
CiteFactor
Sciences of Pharmacy
Sciences of Pharmacy

e-ISSN 2830-7259
p-ISSN 2830-7046
DOI 10.58920/sciphar

Sciences of Pharmacy (SciPhar) is an international, peer-reviewed open-access journal of pharmacy. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript.

Publication on SciPhar is free of charge at any stage. After acceptance, all papers are instantly templated and published online, with an average editorial process time of 1-7 days. Sciphar has 4 issues in each year.

[The reasons for prompt rejection of certain review articles can be found in the author instructions. Please familiarize yourself with the guidelines before submitting]

Scope
Sciphar covers all aspects of pharmacy, including but not limited to:
  • Drug Discovery and Development (ethnopharmacy, pharmacognosy, drug synthesis, excipient synthesis, target identification and validation, lead optimization, drug delivery design, pharmaceutical formulation and characterization, excipient optimization, scale up, industrial manufacturing, and stability test). 
  • Fundamental and Clinical Pharmacology (pharmaceutical activity and effectivity, drug mechanisms, dose studies, pharmacokinetics, pharmacodynamics, drug metabolism, pharmacogenetics, drug-drug interactions, adverse drug reactions, mechanisms of drug toxicity, pharmacovigilance, clinical trials). 
  • Pharmacy Practice, Management, and Administrative (pharmacy regulation and law, administration, management, pharmacoepidemiology, pharmacoeconomics, clinical pharmacy, pharmaceutical marketing).
  • Pharmacoinformatics (digital pharmacy, telepharmacy, chatbot in pharmacy, big pharmacy data, pharmacological clusterization, modelling, pharmacological network analysis, etc).

Contact us at our official email: sciphar@etflin.com

Editor-in-Chief

apt. Abd. Kakhar Umar, M.Pharm
Department of Pharmaceutics and Pharmaceutical Technology, Padjadjaran University, Indonesia
Expertise: Nanoformulation; Liposomes; Stem cell and biomolecules delivery system; Natural product development; Drug characterization; Data analysis; Machine learning in pharmaceutical sciences; Digital pharmacy; Telepharmacy
Google Scholar   ResearchGate   Scopus ID   ORCID


Sectional Editorial Board

Our esteemed editorial board comprises 34 experts from 13 different countries. Our board members bring a diverse range of knowledge, skills, and experiences to the table, enabling us to provide a broad perspective on various issues. 

Section 1: Drug Discovery and Development 
Prof. Yashwant V Pathak, M. Pharm., Executive MBA, MSCM, Ph.D., FAAAS
USF Health Taneja College of Pharmacy, University of South Florida, Florida 33612, USA
Expertise: Nanotechnology; Physical chemistry; Polymer chemistry; Nutraceuticals

Scopus ID   Google Scholar   ResearchGate

Prof. Elena Bakhrushina, Ph.D.
Departament of Pharmaceutical Technology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia
Expertise: Controlled drug delivery; Ocular drug delivery; Pharmaceutical biotechnology; Spray drying; Pharmacokinetics; Biopharmaceutics; Industrial pharmacy; Pharmaceutical analysis; Targeted drug delivery; Solid dosage forms

Google Scholar   ResearchGate   Scopus ID   ORCID

Prof. Dr. apt. Marline Abdassah Bratadiredja, MS
Departement of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
Expertise: Transdermal drug delivery; Cosmetics; Extract formulation

Google Scholar   Scopus ID

Prof. Jittima Amie Luckanagul, Ph.D.
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Expertise: Polymers synthesis; Liposomal delivery system; Vaccines; Nanoparticles

Google Scholar   Scopus ID   Research Gate   ORCID

Prof. Farid Menaa, Ph.D.
Department of Pharmaceutical Sciences and Dermatology, University of California San Diego, California, USA
Expertise: Nanotechnology; Omics; Gene expression; Cancer Stem Cells; Stem Cell Biology; Applied Chemistry; Fluorine Chemistry; Nanobiotechnology; Analytical Chemistry; Molecular Biology; Cell Biology; Genetics; Biochemistry; DNA Damage Response; Molecular Conformation; Protein Folding; Biophysics; Materials Chemistry; Nanomedicine; Preventive Medicine; Radiobiology; Regenerative Medicine; Green Chemistry Technology

ResearchGate   Google Scholar   Scopus ID

Prof. Dr. Moelyono Moektiwardoyo, MS., Apt.
Department of Biology Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia
Expertise: Phytochemicals; Natural product chemistry; Herbal medicine; Ethnopharmacology

ORCID   Google Scholar   Scopus ID   ResearchGate

Prof. Dr. V Vidyashree Nandini,  MDS, DNB, MAMS
SRM Kattankulathur Dental College and Hospital, SRMIST, POTHERI-603203, Kattankulathur Campus, Kattankulathur, Tamil Nadu 603203, India
Expertise: Implant dentistry; Biomaterials; Dental materials; Prosthodontics; Esthetic dentistry; Temporomandibular disorders

Google Scholar   ResearchGate   Scopus ID   ORCID

Prof. apt. Muhammad Sulaiman Zubair, M.Si., Ph.D.
Natural Product Research Group, Department of Pharmacy, Faculty of Science, Tadulako University, Palu 94118, Indonesia
Expertise: Phytochemistry; Organic chemistry; Medicinal chemistry

ORCID   Google Scholar   Scopus ID   Research Gate

Dr. Adeleye Ademola Olutayo, PGDE
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Olabisi Onabanjo University, Ago-Iwoye, Nigeria
Expertise: Drug formulation; Controlled drug delivery; Preformulation; Drug stability; Tablet; Pharmaceutical formulation; Medical nanotechnology; Topical administration

Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. Sayani Bhattacharyya, M.Pharm
Krupanidhi College of Pharmacy, Bengaluru, Karnataka 560035India
Expertise: Solid state behaviour; Cocrystallization; Mesoporous materials; Oral disintegrating films

Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. Morteza Rabiei
Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah 6714414971Iran
Expertise: Server; Biotechnology; Nanobiotechnology; Bioinspired engineering and biomimetic design; Distributed databases
Dr. apt. Garnadi Jafar, M.Si
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung City 40614, Indonesia
Expertise: Herbal formulation

Google Scholar   Scopus ID

Dr. Maryam Bikhof Torbati
Department of Biology, Islamic Azad University-Shahre rey Branch, Tehran 1477893855, Iran
Expertise: Cancer nano drug delivery systems; Molecular biology; Biotechnology; Cell biology; Medicinal chemistry

Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. Ebrahim Tavakoli
Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan, P.O. Box 8174613441, Iran
Expertise: Stem cell therapy; Tissue replacement via advanced materials; and Drug delivery nano-carrier systems

ResearchGate

Dr. Borra N. Dhanunjayarao, M.Tech
Vignans Institute of Information Technology, Visakhapatnam, Andhra Pradesh 530049India
Expertise: 3D and 4D printing; Nano Composites; Smart Materials; Shape Memory Polymer Materials; Optimization Techniques using statistical methods; Mechanical characterization; and Tribology studies for wear behavior.
Google Scholar   ResearchGate   Scopus ID   ORCID



Section 2: Fundamental and Clinical Pharmacology 
Prof. Dr. Pilli Govindaiah
Department of Pathology, School of Medicine, Wayne State University, Detroit, MI 48202, USA

ResearchGate   Google Scholar   ORCID   Scopus ID 

Prof. Khalid Abdelsamea Mohamedahmed, Ph.D.
Department of Hematology and Immunohematology and Department of Immunology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Madani, Sudan
Expertise: Medical Laboratory; Immunology of Infectious Diseases; Flow Cytometry; Cancer Immunology; Laboratory Medicine; Clinical Laboratory Science; Laboratory Diagnostics; Laboratory Science; Blood Sampling; Immunodiagnostics; Infection; Innate Immunity; Immunity; Laboratory Analysis; Medical Laboratory Technology; Adaptive Immunity; Cellular Immunology; Inflammation; PCR; Dendritic Cell Vaccine; Immune Regulation; Macrophage; Clinical Hematology; Human Immunology; Laboratory Management; Laboratory Safety; Laboratory Manuals; Laboratory Equipment; Laboratory Automation; Clinical Diagnostics

ORCID   Scopus ID   ResearchGate   Google Scholar

Dr. Zilin Wei
Key Laboratory of Risk Assessment and Control for Environment & Food Safety, Tianjin Institute of Environmental & Operational Medicine, Tianjin, China
Expertise: Microbiology; Genetics; Bioinformatics

ResearchGate   Scopus ID   Google Scholar

Dr. Constancy Prisca Aleru-Obogai, B.MLS., AMLSN., M.Sc.
Department of Medical Laboratory Science, Rivers State University of Science & Technology, Nkpolu-Oroworukwo, Port Harcourt, Nigeria.
Expertise: Medical Microbiology; Pharmaceutical Microbiology; Diagnostic Parasitology; Medical Mycology; Clinical Bacteriology; Clinical Chemistry; Clinical Infectious Diseases; PCR; Clinical Hematology; Medical Parasitology; Clinical Microbiology; Nosocomial Infection; Diagnostic Microbiology; Antimicrobial Susceptibility Testing; Antimicrobials; Bacteriology; Antibiotic Resistance

ORCID   Google Scholar    Research Gate

Dr. Abdelrahman I. Rezk
Department of Physiology, Medical School, Jeonbuk National University, Jeonju-Si 561-756, Republic of Korea

Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. Mustafa Azizoğlu, MD
Department of Pediatric Surgery, Faculty of Medicine, Dicle University, Turkey.

ORCID



Section 3: Pharmacy Practice, Management, and Administrative
Prof. Dr. Erwin Martinez Faller, RPh., MSPharm.,MMPS., FRIPharm.
School of Allied Health Sciences, Pharmacy Department, San Pedro College, Davao City 8000, Philippines
Expertise: Social pharmacy and administrative; Clinical pharmacy; Pharmacy education

Google Scholar   ResearchGate   Scopus ID   ORCID

Prof. Mohammad B. Nusair, M.Sc., Ph.D.
Sociobehavioral and Administrative Pharmacy Department, Nova Southeastern University, Florida, United States
Expertise: Health Care Management; Health Services Research; Pharmaceutical Care; Mixed Methods; Quantitative and Qualitative Research; Deprescriptions; Polypharmacy; Pharmacy Education

Google Scholar   ResearchGate   Scopus ID   ORCID 

Taehwan Park, Ph.D.
Pharmacy Administration and Public Health, College of Pharmacy and Health Sciences, St. John's University, Queens, 11439, NY, United States
Expertise: Pharmacoeconomic, pharmacoepidemiology, social pharmacy, digital pharmacy, telepharmacy, big pharmacy data

ResearchGate   Scopus ID

Ruth Jeminiwa, Ph.D.
Department of Pharmacy Practice, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia PA, United States
Expertise: Health outcomes research (behavioral health, digital health, pharmacoeconomics)

Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. dr. Cosmos Octavianus Mangunsong, SpM(K)
Indonesian Ophthalmologist Association [IOA] – PERDAMI, Jakarta, Indonesia

Expertise: Telemedicine; Ocular therapy; Stem cell therapy; Regenerative medicine for ocular diseases



Section 4: Pharmacoinformatics
Dr. Ernest Domanaanmwi Ganaa, M.Sc.
ICT department of Hilla Limann Technical University, Ghana
Expertise: Big data in pharmacology, toxicology, and pharmaceutics; Machine learning; Pattern recognition; and Dimensionality reduction

Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. Borra N. Dhanunjayarao, M.Tech
Vignans Institute of Information Technology, Visakhapatnam, Andhra Pradesh 530049, India
Google Scholar   ResearchGate   Scopus ID   ORCID

Dr. Morteza Rabiei
Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah 6714414971, Iran
Expertise: Server; Distributed databases; Bioinspired engineering and biomimetic design

Google Scholar   ResearchGate   ORCID



Managing Editors

Marina M. Shumkova, M.Sc.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia

ORCID   Scopus ID

Angi Nadya Bestari, S.Farm., M.Sc., Apt.
Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta 55281, Indonesia
Google Scholar

Keerthic Aswin, M.Pharm
CSIR-GATE JRF, Institute of Genomics and Integrative Biology, New Delhi, India
Google Scholar   Scopus ID   Research Gate

Apt. Dhanang Prawira Nugraha., S.Farm., M.Farm
Department of Pharmacy, Faculty of Sciences and Technology, Ma Chung University, Malang 65151, Indonesia

Google Scholar

Derevnina Ekaterina AlekseevnaM.Sc.

SOLYUR pharmaceutical company, Moscow 115432, Russia

Georgy Prosvirkin, M.Sc.
Peoples' Friendship University of Russia (RUDN University), Moscow 117198, Russia

Flowchart of Submission Process
ETFLIN Journal Submission

Alert: We do not accept any paper generated by AI. A review paper should contain a discussion of previous works, criticism, comments, suggestions, and/or opinions of the experts (authors) supported by table(s) (previous work list and summary), figure(s) (chart, illustration, etc), and other data. Prompt rejection will be given if these criteria are not met.

"AI allowed, wisdom applied"

Submission and Tracking of manuscript
We use a submission system which can be accessed by registering an account through the Login button (top right).

Manuscript Format
We encourage author to use this template (Download Template). All instructions are within the template and it is easy to follow.  Original Article must contain these sections: Abstract, Introduction, Experimental Section, Results, Discussion (can be combined with results), and Conclusion. For other types of manuscript, any structure is acceptable as long as it contains: Abstract, Introduction/Background, and Conclusion/Summary (a summary can be included within the discussion section).
Types of Manuscript

SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript.

Manuscript Content

Font and Style
If you use our template then you can easily set up the font style. We use Segoi UI font style with font size as follows:

Title : 18 pt
Author name : 12 pt
Section/header : 13 pt
Sub section/sub header : 12 pt
Sub of a sub section : 11 pt

Content, references, and others : 11 pt

Flexible font size
Abstract : 9 - 11 pt (depending on the number of abstract words)
Table and Figure : <11 pt (depending on the clarity, blurrines, and table or figure size)

Title

Title must be clear and represent the whole manuscript content. The maximum title's length is 3 lines in the manuscript template. No abbreviations use unless the full term is included. We use 'Title Capitalization' rules for the paper title, check this good explanation and this APA style for title case rules.

Author name and affiliation
Put a number after the author name according to the affiliation number. If all authors are from the same affiliation, number after author's name is not necessary. Corresponding author should be marked with (*) after his/their name. Please provide all the corresponding emails if you have more than one corresponding author.

Please refrain from including any titles, degrees, or statuses in the authorship information. While we hold utmost respect for academic achievements, our goal is to promote equality in publishing, valuing the work of both young and senior researchers. These statuses could also change during the time.

ORCID logo should only be used if you have an ORCID account and make the logo linked to your ORCID link. You can also input your ORCID ID (not the full link, e.g. 0000-0000-0000-0000) in the authorship input during submission and we will add your ORCID to the final version of the published PDF. 

Abstract
Unstructured abstract, not more than 250 words. The abstract should briefly highlight the background, methods, results, and conclusions of the study.

Keywords

Provide 3-6 unique and diverse keywords. One keyword must not exceed three words and using abbreviations in keywords should be avoided. Choose keywords that highlight the crucial aspects of your work, excluding those already mentioned in the article title or extensively covered in the abstract. Keywords play a significant role in enhancing the visibility of your work in search engines. Therefore, using unique and distinct keywords from the title and abstract allows for a broader and more specific search scope for your work.

Graphical abstract
The graphical abstract ought to present a smooth and coherent overview of the entire research process. Rather than integrating it into the manuscript, please submit the graphical abstract separately. Note that the graphical abstract will only be accessible in the HTML version of the published article.

Quality: Minimum 300 dpi
Although it is optional, our editor may find your graphical abstract appealing and choose it as the issue cover.

Figures

Figure must be clear and labelled. All figures must be included in the manuscript file and positioned as they are mentioned in the text for the first time. Please use bold to the figure number, for example: Figure 1. Flowchart of the methodology. Ensure that you place a period (.) at the end of each caption for figures and tables.

Size: Height = should fit within a single page of the SciPhar template, width = should fit within the SciPhar template
Quality: Minimum 300 dpi

File type: JPG or PNG.

To ensure clarity of both the text and image in the figure, it is crucial to maintain the original aspect ratio when scaling up a figure. Stretching or widening the figure on only one side may cause blurriness and therefore, should be avoided.

Reproduction of figures
To reproduce a figure (already published in a paper in any journal) in SciPhar, copyright permission must be obtained. If a figure is reproduced without permission, it will be considered plagiarism and the authors will be asked to rectify the same. A note like 'copyright has been obtained from Einstein et al.' must be included within the Figure legend.

Tables

Tables must be created with the insert table feature of the Microsoft word. Please do not insert table as an image. All borders must be visible. The table header must be bold. Table number in caption must also be bold. Ensure that you place a period (.) at the end of each caption for figures and tables.

Example: Table 1. Patients’ characteristics.

In the event that a table extends beyond three pages, it is mandated to submit it as a supplemental table in EXCEL format or another datatable file. However, the supplemental table should still be mentioned in the text of the article to maintain its relevance and clarity.

Supplemental Data
To ensure accessibility and ease of use, supplemental data can be shared in the form of a file (ZIP or RAR) submitted with the manuscript or a permanent link to the data storage location. For supplemental data in the form of programs or applications, we recommend using GitHub. It is not acceptable to store the data on a personal cloud account like Gdrive or Onedrive.

Equations
Equations must be created with the insert equation feature of the Microsoft word. Please do not insert equation as an image. Each equation must be centered and labelled with a number.

Decimal

Please use dots as a decimal marker, not commas.

Software to reduce grammatical errors
The use of grammarly is encouraged to minimize grammatical errors. Grammarly can be downloaded, installed, and added as an add-on to the Microsoft Word document.

Reference managing software
Authors are encouraged to use software such as Mendeley, Zotero, etc. to arrange the references. Mendeley and Zotero can be downloaded and installed. Once installed, they will appear on the 'References' tab on the Microsoft Word document.

Reference Style

We accept Vancouver style.

Funding Information
Please include funding information in your manuscript if you receive one. Full name of the funding agency and the grants number must be included. 

Authorship policy
In terms of planning the study design, data analysis, statistical analysis, software, executing work, writing, and editing, a significant contribution should be made by all contributing authors such as the first author, co-authors, and corresponding authors. Authors are encouraged to get familiar with the Committee on Publication Ethics (COPE) guidelines.

Corresponding author
The corresponding author will take the responsibility of communicating with the editors from the initial submission till publication. Depending on the requirement, there may be two corresponding authors. In the case of two corresponding authors, the asterisk '*' sign should accompany their names in the manuscript and the initials of the authors should accompany their email addresses in the manuscript.

Change of authorship
During the review process, the corresponding author may request that the authorship be changed, providing appropriate reasons for the request. It is not permitted to add or remove authors once a submission has been accepted.

Plagiarism
If possible, authors are requested to submit a plagiarism report from commercial software (or from a free online server) as a supplemental data. For all types of articles, the plagiarism percentage should be kept as low as possible (maximum upper limit 15% excluding references). Even if the plagiarism percentage remains below 15%, the authors may be further asked to reduce the plagiarism to increase the authenticity of the manuscript.

Animal ethics and cell lines
Studies should be carried out keeping in mind the standard guidelines set by OECD, CPCSEA, ICH, Animal Welfare Board of India, as well as other organizations. Ethical clearance with proper documents should be obtained from the concerned authority (for example, Institutional Animal Ethics Committee) to carry out the studies. Also, sufficient details regarding the document number should be mentioned in the manuscript. 

Retraction
Retraction guidelines provided by the Committee on Publication Ethics (COPE) will be followed. A notice of retraction will be given to a paper if the findings are unreliable, unethical, plagiarized, or manipulated. To maintain integrity, the retracted paper will remain visible on the e-bulletin page. However, a notice of retraction will accompany the paper.

DOAJ
EBSCO
Scilit
Garuda
Crossref
Harvard Library
Universiteit Leiden
Google Scholar
Index Copernicus
DRJI
WorldCat
BASE
ROAD
OAISter
CiteFactor

Dr Ratri Rokhani (Google Scholar)
Pharmacology Laboratory, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Banyumas 53182, Indonesia

Dr Irma Rahayu Latarissa (Google Scholar)
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia

Dr Shouvik Kumar Nandy (Google Scholar)
Assistant Professor in Pharmacology at Burdwan Institute of Pharmacy, Purba Barddhaman 713103, India

Dr apt. Adhe Septa Ryant Agus, M.Farm., AAAK. (Google Scholar)
STIKes Dirgahayu Samarinda

Dr Bikram Dutta Tassa (Google Scholar)
Associate Professor, Department of Pharmacology, Assam Medical College and Hospital, Dibrugarh.

Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia

Dr Bachtiar Rivai (Google Scholar)
Pharmaceutical Science and Technology, Chulalongkorn University, Bangkok, 10330, Thailand

Dr Yuniarti Falya (Google Scholar)
Sekolah Tinggi Farmasi Muhammadiyah Cirebon, Indonesia

Dr Mrinmoy Chakraborty (Google Scholar)
Department of Pharmaceutical Science, Kumaun University, Nainital 263002, India

Dr Maria Elvina Tresia Butar-Butar (Google Scholar)
Pharmacy Study Program, College of Health Sciences Dirgahayu, Samarinda 75122, Indonesia

Dr Ivan Ivanovich Krasnyuk (jr.) (Google Scholar)
PhD, Professor, Head of Department of Pharmaceutical Technology A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University)

Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia

Dr Elizaveta Valeryevna Melnik (Google Scholar)
Department of Pharmaceutical and Toxicological Chemistry named after A.P. Arzamastsev, Sechenov University

Dr Faruk Jayanto Kelutur (Google Scholar)
Department of Pharmaceutical Science and Medicinal Chemistry, Faculty of Pharmacy, Sumedang, Universitas Padjadjaran, Indonesia

Dr Yuniarti Falya (Google Scholar)
Sekolah Tinggi Farmasi Muhammadiyah Cirebon

Dr apt. Erma Yunita, M.Sc. (Google Scholar)
Akademi Farmasi Indonesia, Yogyakarta, Indonesia

Prof Elena O. Bakhrushina (Google Scholar)
Department of Pharmaceutical Technology, A.P.Nelyubin Institute of Pharmacy and PHARMA-PREMIUM scientific educational center, Sechenov University.

Dr Bachtiar Rivai (Google Scholar)
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand

Dr Sk Mizanul Haque (Google Scholar)
Department of Scientometrics, Library and Information Sciences, University of Calcutta, Kolkata, India

Dr Agus Rusdin (Google Scholar)
Department of Pharmacy, Bandung Health Polytechnic, West Java, Indonesia.

Dr Mayang Kusuma Dewi (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia

Dr Lalrinmawii (Google Scholar)
Medical Officer at Keitum Health & Wellness Centre under National Ayush Mission, Government of India

Dr Hardika Aditama (Google Scholar)
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia

Dr Ridho Islamie (Google Scholar)
Departemen Farmasi Klinis dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Surabaya 60293, Indonesia

Dr James H. Zothantluanga (Google Scholar)
Dibrugarh University

Dr Iksen (Google Scholar)
Departemen Farmasi, Sekolah Tinggi Ilmu Kesehatan Senior Medan,

Dr Mia Nisrina Ambar Fatin (Google Scholar)
Fakultas Farmasi, Universitas Bhakti Kencana, Bandung, Indonesia

Dr Muhammad Fauzi (Google Scholar)
Departement of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia

Dr Amelia Soyata (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia

Dr Reza Pratama (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Cibiru 40614 Indonesia

Dr Novaliana Devianti Sagita (Google Scholar)
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Cibiru 40614 Indonesia

Any enquiry related to the journal, please reach us through email below. Sciences of Pharmacy editorial's email: sciphar@etflin.com

Office: Sungai Manonda Street, Duyu, Tatanga,
Palu City 94225, Indonesia.
WhatsApp: +62 82216335184
Publisher email: halo@etflin.com

Peer-review Process

After submission of a manuscript, one of the editorial members will examine the quality of the manuscript. If the manuscript falls within the journal scope and showed high quality content, the editor will assign a minimum of two reviewers for the manuscript. After peer-review, the editor will make a decision based on the reviewer comments and recommendation. The decision made by the editor will be final. The journal follows a double-blind peer-review wherein the information of reviewers and authors are blinded from each other during the entire peer-review process. Please take a look at the Manuscript Lifecycle for detailed information.

Open Access Policy

All papers published in the journal are freely accessible immediately after publication. The papers are freely available to read, shared, and reproduced in any form with proper citation to the original work. Open access is a property of individual works and community standards that will enforce proper attribution and responsible use of the published work.

Author Charges

Publishing a paper in the journal is free. The journal do not take submission fees, editorial processing charges, article processing charges, page charges, or color charges.

Licensing Terms

The journal is licensed under the Creative Commons Attribution (CC BY) 4.0 International License. Detailed Licences Policy

Plagiarism

Plagiarism is not tolerated in ETFLIN journals. Plagiarism is defined as the act of copying words, ideas, images, or data from another source, including your own publications, without crediting the original source. Text copied from another source must be reused between quotation marks, and the original source must be cited. If the design of a study, or the style or language of the article, was inspired by past research, it must be fully cited.

The industry standard program Turnitin is used to check all ETFLIN submissions for plagiarism. The manuscript may be rejected if plagiarism is discovered during the peer review process. If plagiarism is discovered after publication, an inquiry will be conducted and appropriate action will be taken in accordance with our policy.

Latest Articles

Research Article

Psychotropic Drugs Used in Psychiatry Outpatient Department: A Cross-Sectional Drug Utilization Research

by Hiteswar Saikia, Mustakim Ahmed, Anju L. Saikia, Daisy Phukan
Sciences of Pharmacy; Vol 2, Issue 3; 06 July 2023
https://doi.org/10.58920/sciphar02030042

Abstract: Mental and behavioral disorders are common around the world. Pharmacotherapy, psychotherapy, and psychosocial rehabilitation are three treatment components for these disorders. Drug therapy is an essential part of the comprehensive treatment of these diseases. Their use pattern in psychiatric practi [...] Show more.
Abstract: Mental and behavioral disorders are common around the world. Pharmacotherapy, psychotherapy, and psychosocial rehabilitation are three treatment components for these disorders. Drug therapy is an essential part of the comprehensive treatment of these diseases. Their use pattern in psychiatric practice has changed dramatically in recent years. Mental disorders require long-term treatment. Therefore, it is crucial to study the prescribing practices of these groups of drugs. This study aims to assess drug use patterns using the WHO/INRUD Core Prescribing Indicators. Patients of both genders and ages with mental illness and prescription psychiatric drugs were evaluated from the outpatient department of the Psychiatry Unit (OPD). The prescription data were collected and analyzed using the indicators recommended by the WHO/INRUD. The data were analyzed using Microsoft Excel-2007. The percentage and average values of the variables were compared. A total of 655 prescriptions were analyzed. Male patients (54.96%) were more than women (45.04%). The morbidity profile included schizophrenia (37.86%), alcohol use disorder (18.78%), major depressive disorder (11.30%), anxiety disorder (10.23%), bipolar disorder (4.88%), and others (16.95%). The newer antipsychotic were the most commonly prescribed drugs (particularly olanzapine), along with a central anticholinergic (trihexyphenidyl) and a benzodiazepine (lorazepam). The percentage of drugs prescribed with generic names was 39.80%, and that of drugs prescribed by NLEM was 48.49%. The average number of drugs prescribed per prescription was 2.58. This study's Index of Rational Prescribing (IRDP) was 3.87, whereas the optimal score was 5. Prescriptions were complete, and principles of rational prescribing were followed, except for a low generic prescribing rate. Show less...

Review

Comparison of Microsampling and Conventional Sampling Techniques for Quantification of Warfarin in Blood Samples: A Systematic Review

by Callista Andinie Mulyadi, Yahdiana Harahap, Hary Sakti Muliawan
Sciences of Pharmacy; Vol 2, Issue 3; 06 July 2023
https://doi.org/10.58920/sciphar02030055

Abstract: Warfarin is a vitamin K antagonist (VKAs) anticoagulant associated with interindividual patients’ response to therapy, narrow therapeutic index, and serious adverse drug events. Monitoring ensures efficacy and safety by measuring drug concentration in the bloodstream, which demands blood or plasma [...] Show more.
Abstract: Warfarin is a vitamin K antagonist (VKAs) anticoagulant associated with interindividual patients’ response to therapy, narrow therapeutic index, and serious adverse drug events. Monitoring ensures efficacy and safety by measuring drug concentration in the bloodstream, which demands blood or plasma samples from patients through conventional sampling. Conventional sampling often requires invasive methods that may be uncomfortable for patients. Microsampling offers an opportunity to reduce the burden of multiple blood sampling on patients and simplifies the process of sample transportation and storage. This systematic review describes conventional and microsampling techniques for quantifying warfarin in human blood samples and the bioanalytical method employed to perform the analysis. Related studies (537) were screened from several databases and narrowed down into 12 eligible articles, which were then used to fulfill the purpose of this review in a narrative form. It is concluded that while there are still limited studies regarding the application of microsampling for warfarin quantification in patients, there has been evidence of comparable plasma and micro samples results, highlighting the potential for future development of routine monitoring using the microsampling technique. Show less...

Review

Chatbots in Pharmacy: A Boon or a Bane for Patient Care and Pharmacy Practice?

by Chusnul Nur Ramadhani
Sciences of Pharmacy; Vol 2, Issue 3; 03 July 2023
https://doi.org/10.58920/sciphar02030001

Abstract: Chatbots in pharmacies have gained popularity in recent years, potentially revolutionizing patient care and pharmacist workflow. However, whether chatbots are, a boon or a bane for the pharmacy profession remains. This review article aims to comprehensively analyze the literature on chatbots in phar [...] Show more.
Abstract: Chatbots in pharmacies have gained popularity in recent years, potentially revolutionizing patient care and pharmacist workflow. However, whether chatbots are, a boon or a bane for the pharmacy profession remains. This review article aims to comprehensively analyze the literature on chatbots in pharmacy, including their benefits, limitations, and future directions. Findings suggest that chatbots have the potential to improve medication adherence, provide patient education, and streamline pharmacist workflow. However, there are limitations to their use, such as the need for robust natural language processing algorithms and concerns regarding patient privacy and security. Furthermore, the lack of regulatory oversight and standardized development processes may hinder their widespread adoption. Overall, while chatbots have the potential to improve certain aspects of pharmacy practice, caution must be taken to ensure their accuracy and safety. Moreover, chatbots should be viewed as a tool to support pharmacists in providing high-quality patient care rather than replacing the valuable expertise and human connection pharmacists provide. Further research is needed to explore the full potential of chatbots in pharmacy practice and to address the limitations and concerns highlighted in this review. Show less...

Research Article

Phytochemical Analysis, In-vitro, and In-silico Antibacterial Activity of Stembark Extract of Anogeissus leiocarpus (DC) Guill and Perr

by Mubarak Muhammad Dahiru, AbdulAzeez Mumsiri Abaka, Neksumi Musa
Sciences of Pharmacy; Vol 2, Issue 3; 05 June 2023
https://doi.org/10.58920/sciphar02030024

Abstract: Bacterial infections subsequently leading to antibiotic resistance has been a leading cause of mortality and morbidity worldwide especially in developing countries with high poverty rate and poor healthcare system. Thus, prompting the prospect in alternative therapy such as medicinal plants. In the [...] Show more.
Abstract: Bacterial infections subsequently leading to antibiotic resistance has been a leading cause of mortality and morbidity worldwide especially in developing countries with high poverty rate and poor healthcare system. Thus, prompting the prospect in alternative therapy such as medicinal plants. In the present study, we evaluated the antibacterial action of stem bark extract of Anogeissus leiocarpus (AL) Guill and Perr. as applied in folkloric medicine for antibacterial purposes. The phytochemicals present in the plant extract were identified and quantified, followed by the determination of the antibacterial effects of the extract against Escherichia coli and Staphylococcus aureus. Molecular docking study was carried out to ascertain the inhibitory effects of compounds from AL against bacterial enzymes. Alkaloids (7.17% ±0.60), saponins (11.33% ±3.18), and flavonoids (31.01% ±4.04) were detected. A maximum ZI was observed for E. coli compared to S. aureus at the highest extract concentration (100 mg/mL) with amoxicillin having superior ZI at 50 mg/mL concentration. The MIC against E. coli and S. aureus were 12.5 mg/mL and ≤ 6.25 mg/mL respectively while the MBC was>100 mg/mL and 100 mg/mL respectively. Among the identified compounds, IX exhibited the least binding affinity (BA) (7.2 kcal/mol) and inhibition constant (Ki) (5 µM) against UDP-N-acetylglucosamine Enolpyruvyl Transferase (Mur A) compared to all the other targets. AL demonstrated antibacterial activity evidenced by the bacterial growth inhibition, bactericidal potential, and in-silico study revealing high affinity of the bacterial enzymes for the identified compounds, thereby supporting the acclaimed antibacterial use of the plant in folkloric medicine. Show less...

Review

Cold Atmospheric Plasma: A Noteworthy Approach in Medical Science

by Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, Arzoo Newar, Sindhuja Sengupta, Padmanath Pegu, Nikita Dey, Shekhar Chandra Bora, Dhunusmita Barman
Sciences of Pharmacy; Vol 2, Issue 2; 11 May 2023
https://doi.org/10.58920/sciphar02020046

Abstract: Cold atmospheric plasma (CAP) is a novel technology with boundless significance that can be used in the medical sector that offers noninvasive in-vivo applications without damaging the living tissues. CAPs can be obtained by curtailing the concentration of high-energetic electrons per phase and by f [...] Show more.
Abstract: Cold atmospheric plasma (CAP) is a novel technology with boundless significance that can be used in the medical sector that offers noninvasive in-vivo applications without damaging the living tissues. CAPs can be obtained by curtailing the concentration of high-energetic electrons per phase and by freezing molecules/atoms (devoid of charge) in plasma utilizing gas circulation and atmospheric air, which includes a variety of charged and neutral reactive entities, UV rays, electric currents, and fields, etc. that have an influence on cellular material in a multitude of diverse manners. Reactive oxygen species (ROS) and reactive nitrogen species (RNS), produced by the plasma, essentially cause biological and therapeutically advantageous plasma effects. CAP plasma has several important biological functions, including the deactivation of pathogens, induction of tissue restoration and cell propagation, the annihilation of cells by triggering apoptosis, etc. Several fundamental concepts are defined, even if the precise process of the effect of plasma on biomolecules is still not properly identified. Depending on the biological synthesis of RNS and ROS in reactions to plasma emissions, the present review described several aspects of plasma therapy in neuroscience, particularly in anti-glioblastoma, neuro-differentiation, and neuroprotection and also the various applications of CAP in medical fields where it is used in the therapy of SARS-CoV-2, cancer therapy, and chronic and acute wounds. Furthermore, the proliferation in stem cells, dental medicines, dermatology, and a brief insight into CAP devices and their risk factors was highlighted. Show less...
Top Visited Articles

We Computerize Sciences, We Publish Sciences, We Are Scientist

ETFLIN

  • Our Product and Service
  • Software
  • Education and Training
  • Article Services
  • In Silico Study
  • Marketplace

Become our peer-reviewer

Join us in shaping the future of scholarly research and making a meaningful contribution to academia.

Newsletter

Receive any update from us

We are open for collaboration in any fields to improve health systems

Please reach us on our social media below.
ETFLIN Social ETFLIN Social ETFLIN Social ETFLIN Social ETFLIN Social ETFLIN Social
© 2015 - 2023 ETFLIN (Palu, Indonesia)